Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Spengler

Showing results (161-170 of 224) with videos related to

Pageof 23
Sort By:
Journal of Hepatology|May 21, 2008
The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infectionAndrej Potthoff, Heiner Wedemeyer, Wulf O Boecher, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 23, 2019
The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieuHans Dieter Nischalke, Philipp Lutz, Eva Bartok, et al.
European Journal of Immunology|October 16, 2009
Regulation of NK cell trafficking by CD81Benjamin Krämer, Daniela Schulte, Christian Körner, et al.
European Journal of Immunology|March 30, 2004
Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virusOri Wald, Orit Pappo, Rifaat Safadi, et al.
Gastroenterology|July 6, 2010
Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitisMichael P Manns, Marek Woynarowski, Wolfgang Kreisel, et al.
BMC Infectious Diseases|January 24, 2023
Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIVLeona Dold, Mette J Nielsen, Michael Praktiknjo, et al.
Journal of Medical Virology|September 15, 2007
Fifteen years of env C2V3C3 evolution in six individuals infected clonally with human immunodeficiency virus type 1Bernd Kupfer, Tobias Sing, Peter Schüffler, et al.
Hepatology (Baltimore, Md.)|August 16, 2014
Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patientsEvrim Anadol, Robert Schierwagen, Natalia Elfimova, et al.
Plos One|July 12, 2019
Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cARTLeona Dold, Mette J Nielsen, Michael Praktiknjo, et al.
Gut|September 9, 2016
Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohortTania M Welzel, Jörg Petersen, Kerstin Herzer, et al.
Pageof 23

Showing results (161-170 of 224) with videos related to

Sort By:
Pageof 23
Journal of Hepatology|May 21, 2008
The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infectionAndrej Potthoff, Heiner Wedemeyer, Wulf O Boecher, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 23, 2019
The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieuHans Dieter Nischalke, Philipp Lutz, Eva Bartok, et al.
European Journal of Immunology|October 16, 2009
Regulation of NK cell trafficking by CD81Benjamin Krämer, Daniela Schulte, Christian Körner, et al.
European Journal of Immunology|March 30, 2004
Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virusOri Wald, Orit Pappo, Rifaat Safadi, et al.
Gastroenterology|July 6, 2010
Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitisMichael P Manns, Marek Woynarowski, Wolfgang Kreisel, et al.
BMC Infectious Diseases|January 24, 2023
Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIVLeona Dold, Mette J Nielsen, Michael Praktiknjo, et al.
Journal of Medical Virology|September 15, 2007
Fifteen years of env C2V3C3 evolution in six individuals infected clonally with human immunodeficiency virus type 1Bernd Kupfer, Tobias Sing, Peter Schüffler, et al.
Hepatology (Baltimore, Md.)|August 16, 2014
Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patientsEvrim Anadol, Robert Schierwagen, Natalia Elfimova, et al.
Plos One|July 12, 2019
Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cARTLeona Dold, Mette J Nielsen, Michael Praktiknjo, et al.
Gut|September 9, 2016
Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohortTania M Welzel, Jörg Petersen, Kerstin Herzer, et al.
Pageof 23